Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedA notice appears above the page announcing NIH website-transition updates and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header and a Home button, indicating access to the study record is blocked.SummaryDifference20%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a new build of the site. This update does not change the displayed study details or how users interact with the page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study record now shows the trial as Completed with updated dates and a new Informed Consent Form linked under Study Documents; the previous Active, not recruiting status and related dates have been removed.SummaryDifference1.0%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.